{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:41:58Z","timestamp":1794238918341,"version":"4.9.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8197080313"],"award-info":[{"award-number":["8197080313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970889"],"award-info":[{"award-number":["31970889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Foundation of Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["201901070007E00022"],"award-info":[{"award-number":["201901070007E00022"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["20JC1417700"],"award-info":[{"award-number":["20JC1417700"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["21140903300"],"award-info":[{"award-number":["21140903300"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cryptococcosis is a potentially lethal disease that is primarily caused by the fungus\n                    <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                    , treatment options for cryptococcosis are limited. Here, we show glucuronoxylomannan, the major polysaccharide component of\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    , induces the recruitment of neutrophilic myeloid-derived suppressor cells in mice and patients with cryptococcosis. Depletion of neutrophilic myeloid-derived suppressor cells enhances host defense against\n                    <jats:italic>C. neoformans<\/jats:italic>\n                    infection. We identify C-type lectin receptor-2d recognizes glucuronoxylomannan to potentiate the immunosuppressive activity of neutrophilic myeloid-derived suppressor cells by initiating p38-mediated production of the enzyme arginase-1, which inhibits T-cell mediated antifungal responses. Notably, pharmacological inhibition of arginase-1 expression by a specific inhibitor of p38, SB202190, or an orally available receptor tyrosine kinase inhibitor, vandetanib, significantly enhances T-cell mediated antifungal responses against cryptococcosis. These data reveal a crucial suppressive role of neutrophilic myeloid-derived suppressor cells during cryptococcosis and highlight a promising immunotherapeutic application by inhibiting arginase-1 production to combat infectious diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31723-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:05:43Z","timestamp":1657757143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection"],"prefix":"10.1038","volume":"13","author":[{"given":"Ya-Nan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-544X","authenticated-orcid":false,"given":"Jie-Ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7245-5560","authenticated-orcid":false,"given":"Xin-Ming","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"31723_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham, R. et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect. Dis. 17, 873\u2013881 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"31723_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.fgb.2014.11.006","volume":"78","author":"JF Gibson","year":"2015","unstructured":"Gibson, J. F. & Johnston, S. A. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis. Fungal Genet. Biol. 78, 76\u201386 (2015).","journal-title":"Fungal Genet. Biol."},{"key":"31723_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/374849","volume":"36","author":"A Vibhagool","year":"2003","unstructured":"Vibhagool, A. et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin. Infect. Dis. 36, 1329\u20131331 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"31723_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ni1408","volume":"8","author":"PR Taylor","year":"2007","unstructured":"Taylor, P. R. et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8, 31\u201338 (2007).","journal-title":"Nat. Immunol."},{"key":"31723_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.immuni.2010.05.001","volume":"32","author":"S Saijo","year":"2010","unstructured":"Saijo, S. et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32, 681\u2013691 (2010).","journal-title":"Immunity"},{"key":"31723_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2013.05.017","volume":"39","author":"LL Zhu","year":"2013","unstructured":"Zhu, L. L. et al. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 39, 324\u2013334 (2013).","journal-title":"Immunity"},{"key":"31723_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/13693780400011112","volume":"42","author":"A Roeder","year":"2004","unstructured":"Roeder, A. et al. Toll-like receptors as key mediators in innate antifungal immunity. Med. Mycol. 42, 485\u2013498 (2004).","journal-title":"Med. Mycol."},{"key":"31723_CR8","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.ppat.0020120","volume":"2","author":"LE Yauch","year":"2006","unstructured":"Yauch, L. E., Lam, J. S. & Levitz, S. M. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2, e120 (2006).","journal-title":"PLoS Pathog."},{"key":"31723_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1567-1364.2006.00072.x","volume":"6","author":"C Monari","year":"2006","unstructured":"Monari, C., Bistoni, F. & Vecchiarelli, A. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. 6, 537\u2013542 (2006).","journal-title":"FEMS Yeast Res."},{"key":"31723_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson, P. R. et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat. Rev. Neurol. 13, 13\u201324 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"31723_CR11","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.4049\/jimmunol.174.6.3461","volume":"174","author":"C Monari","year":"2005","unstructured":"Monari, C. et al. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. J. Immunol. 174, 3461\u20133468 (2005).","journal-title":"J. Immunol."},{"key":"31723_CR12","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1462-5822.2008.01125.x","volume":"10","author":"SN Villena","year":"2008","unstructured":"Villena, S. N. et al. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol. 10, 1274\u20131285 (2008).","journal-title":"Cell Microbiol."},{"key":"31723_CR13","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/iai.59.11.3883-3888.1991","volume":"59","author":"HL Collins","year":"1991","unstructured":"Collins, H. L. & Bancroft, G. J. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect. Immun. 59, 3883\u20133888 (1991).","journal-title":"Infect. Immun."},{"key":"31723_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/IAI.66.2.664-669.1998","volume":"66","author":"C Retini","year":"1998","unstructured":"Retini, C., Vecchiarelli, A., Monari, C., Bistoni, F. & Kozel, T. R. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 66, 664\u2013669 (1998).","journal-title":"Infect. Immun."},{"key":"31723_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1128\/iai.61.2.464-469.1993","volume":"61","author":"CH Mody","year":"1993","unstructured":"Mody, C. H. & Syme, R. M. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans. Infect. Immun. 61, 464\u2013469 (1993).","journal-title":"Infect. Immun."},{"key":"31723_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1086\/426511","volume":"191","author":"C Monari","year":"2005","unstructured":"Monari, C. et al. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J. Infect. Dis. 191, 127\u2013137 (2005).","journal-title":"J. Infect. Dis."},{"key":"31723_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/mmy.38.6.407.417","volume":"38","author":"A Vecchiarelli","year":"2000","unstructured":"Vecchiarelli, A. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38, 407\u2013417 (2000).","journal-title":"Med. Mycol."},{"key":"31723_CR18","doi-asserted-by":"crossref","unstructured":"Gabrilovich, D. I. et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67, 425; author reply 426 (2007).","DOI":"10.1158\/0008-5472.CAN-06-3037"},{"key":"31723_CR19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3389\/fimmu.2018.02317","volume":"9","author":"K Abdissa","year":"2018","unstructured":"Abdissa, K. et al. Presence of infected Gr-1(int)CD11b(hi)CD11c(int) monocytic myeloid derived suppressor cells subverts T-cell response and is associated with impaired dendritic cell function in Mycobacterium avium-infected mice. Front. Immunol. 9, 2317 (2018).","journal-title":"Front. Immunol."},{"key":"31723_CR20","doi-asserted-by":"publisher","unstructured":"Ribechini, E. et al. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.128664 (2019).","DOI":"10.1172\/jci.insight.128664"},{"key":"31723_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","volume":"190","author":"JK Knaul","year":"2014","unstructured":"Knaul, J. K. et al. Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 190, 1053\u20131066 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"31723_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.24700","volume":"55","author":"RS Tacke","year":"2012","unstructured":"Tacke, R. S. et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55, 343\u2013353 (2012).","journal-title":"Hepatology"},{"key":"31723_CR23","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.4049\/jimmunol.1501881","volume":"196","author":"CC Goh","year":"2016","unstructured":"Goh, C. C. et al. Hepatitis C virus-induced myeloid-derived suppressor cells suppress NK cell IFN-gamma production by altering cellular metabolism via arginase-1. J. Immunol. 196, 2283\u20132292 (2016).","journal-title":"J. Immunol."},{"key":"31723_CR24","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1002\/eji.201040911","volume":"40","author":"JA Van Ginderachter","year":"2010","unstructured":"Van Ginderachter, J. A., Beschin, A., De Baetselier, P. & Raes, G. Myeloid-derived suppressor cells in parasitic infections. Eur. J. Immunol. 40, 2976\u20132985 (2010).","journal-title":"Eur. J. Immunol."},{"key":"31723_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162\u2013174 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"31723_CR26","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn, J. I., Nagaraj, S., Collazo, M. & Gabrilovich, D. I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791\u20135802 (2008).","journal-title":"J. Immunol."},{"key":"31723_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1189\/jlb.0311177","volume":"91","author":"JI Youn","year":"2012","unstructured":"Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K. & Gabrilovich, D. I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91, 167\u2013181 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"31723_CR28","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1172\/JCI74056","volume":"124","author":"T Condamine","year":"2014","unstructured":"Condamine, T. et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J. Clin. Investig. 124, 2626\u20132639 (2014).","journal-title":"J. Clin. Investig."},{"key":"31723_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1128\/EC.3.2.385-392.2004","volume":"3","author":"J Garcia-Rivera","year":"2004","unstructured":"Garcia-Rivera, J., Chang, Y. C., Kwon-Chung, K. J. & Casadevall, A. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell 3, 385\u2013392 (2004).","journal-title":"Eukaryot Cell"},{"key":"31723_CR30","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3389\/fimmu.2018.01781","volume":"9","author":"HR Huang","year":"2018","unstructured":"Huang, H. R. et al. Dectin-3 recognizes glucuronoxylomannan of Cryptococcus neoformans serotype AD and Cryptococcus gattii serotype B to initiate host defense against cryptococcosis. Front Immunol. 9, 1781 (2018).","journal-title":"Front Immunol."},{"key":"31723_CR31","doi-asserted-by":"publisher","first-page":"29043","DOI":"10.1074\/jbc.M312518200","volume":"279","author":"CT Gange","year":"2004","unstructured":"Gange, C. T. et al. Characterization of sugar binding by osteoclast inhibitory lectin. J. Biol. Chem. 279, 29043\u201329049 (2004).","journal-title":"J. Biol. Chem."},{"key":"31723_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/EC.00306-06","volume":"6","author":"ME Maxson","year":"2007","unstructured":"Maxson, M. E., Dadachova, E., Casadevall, A. & Zaragoza, O. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell 6, 95\u2013109 (2007).","journal-title":"Eukaryot Cell"},{"key":"31723_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/eji.201545509","volume":"45","author":"S Kita","year":"2015","unstructured":"Kita, S. et al. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A. Eur. J. Immunol. 45, 1605\u20131613 (2015).","journal-title":"Eur. J. Immunol."},{"key":"31723_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1358\/dot.2010.46.9.1516989","volume":"46","author":"A Morabito","year":"2010","unstructured":"Morabito, A. et al. Vandetanib: an overview of its clinical development in NSCLC and other tumors. Drugs Today 46, 683\u2013698 (2010).","journal-title":"Drugs Today"},{"key":"31723_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmed.2019.00129","volume":"6","author":"D Decote-Ricardo","year":"2019","unstructured":"Decote-Ricardo, D. et al. Immunomodulatory role of capsular polysaccharides constituents of Cryptococcus neoformans. Front. Med. 6, 129 (2019).","journal-title":"Front. Med."},{"key":"31723_CR36","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1128\/IAI.69.10.6064-6073.2001","volume":"69","author":"C Retini","year":"2001","unstructured":"Retini, C. et al. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect. Immun. 69, 6064\u20136073 (2001).","journal-title":"Infect. Immun."},{"key":"31723_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.chom.2015.02.007","volume":"17","author":"N Rieber","year":"2015","unstructured":"Rieber, N. et al. Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells. Cell Host Microbe 17, 507\u2013514 (2015).","journal-title":"Cell Host Microbe"},{"key":"31723_CR38","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1348-0421.2007.tb04007.x","volume":"51","author":"K Nakamura","year":"2007","unstructured":"Nakamura, K. et al. Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol. Immunol. 51, 1115\u20131119 (2007).","journal-title":"Microbiol. Immunol."},{"key":"31723_CR39","doi-asserted-by":"publisher","first-page":"e0173866","DOI":"10.1371\/journal.pone.0173866","volume":"12","author":"NM Walsh","year":"2017","unstructured":"Walsh, N. M., Wuthrich, M., Wang, H., Klein, B. & Hull, C. M. Characterization of C-type lectins reveals an unexpectedly limited interaction between Cryptococcus neoformans spores and Dectin-1. PLoS ONE 12, e0173866 (2017).","journal-title":"PLoS ONE"},{"key":"31723_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1128\/IAI.02835-14","volume":"83","author":"Y Nakamura","year":"2015","unstructured":"Nakamura, Y. et al. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans. Infect. Immun. 83, 671\u2013681 (2015).","journal-title":"Infect. Immun."},{"key":"31723_CR41","doi-asserted-by":"publisher","first-page":"e0169347","DOI":"10.1371\/journal.pone.0169347","volume":"12","author":"A Campuzano","year":"2017","unstructured":"Campuzano, A., Castro-Lopez, N., Wozniak, K. L., Leopold Wager, C. M. & Wormley, F. L. Jr. Dectin-3 is not required for protection against Cryptococcus neoformans infection. PLoS ONE 12, e0169347 (2017).","journal-title":"PLoS ONE"},{"key":"31723_CR42","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.4049\/jimmunol.175.12.7791","volume":"175","author":"H Aldemir","year":"2005","unstructured":"Aldemir, H. et al. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 175, 7791\u20137795 (2005).","journal-title":"J. Immunol."},{"key":"31723_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2019.11.013","volume":"52","author":"JJ Lai","year":"2020","unstructured":"Lai, J. J., Cruz, F. M. & Rock, K. L. Immune sensing of cell death through recognition of histone sequences by C-type lectin-receptor-2d causes inflammation and tissue injury. Immunity 52, 123\u2013135.e126 (2020).","journal-title":"Immunity"},{"key":"31723_CR44","doi-asserted-by":"publisher","unstructured":"Law, A. M. K., Valdes-Mora, F. & Gallego-Ortega, D. Myeloid-derived suppressor cells as a therapeutic target for cancer. Cells https:\/\/doi.org\/10.3390\/cells9030561 (2020).","DOI":"10.3390\/cells9030561"},{"key":"31723_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-464","volume":"10","author":"JD Veltman","year":"2010","unstructured":"Veltman, J. D. et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer 10, 464 (2010).","journal-title":"BMC Cancer"},{"key":"31723_CR46","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1084\/jem.20061104","volume":"203","author":"P Serafini","year":"2006","unstructured":"Serafini, P. et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J. Exp. Med. 203, 2691\u20132702 (2006).","journal-title":"J. Exp. Med."},{"key":"31723_CR47","first-page":"41","volume":"7","author":"S Lin","year":"2017","unstructured":"Lin, S. et al. Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC. Am. J. Cancer Res. 7, 41\u201352 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"31723_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-14-1716","volume":"21","author":"JA Califano","year":"2015","unstructured":"Califano, J. A. et al. Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma. Clin. Cancer Res. 21, 30\u201338 (2015).","journal-title":"Clin. Cancer Res."},{"key":"31723_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-2008-1063853","volume":"29","author":"JN Jarvis","year":"2008","unstructured":"Jarvis, J. N. & Harrison, T. S. Pulmonary cryptococcosis. Semin Respir. Crit. Care Med. 29, 141\u2013150 (2008).","journal-title":"Semin Respir. Crit. Care Med."},{"key":"31723_CR50","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/nprot.2014.134","volume":"9","author":"H Yang","year":"2014","unstructured":"Yang, H., Wang, H. & Jaenisch, R. Generating genetically modified mice using CRISPR\/Cas-mediated genome engineering. Nat. Protoc. 9, 1956\u20131968 (2014).","journal-title":"Nat. Protoc."},{"key":"31723_CR51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature25974","volume":"555","author":"MHT Stappers","year":"2018","unstructured":"Stappers, M. H. T. et al. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus. Nature 555, 382\u2013386 (2018).","journal-title":"Nature"},{"key":"31723_CR52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chom.2016.09.008","volume":"20","author":"A Vitenshtein","year":"2016","unstructured":"Vitenshtein, A. et al. NK cell recognition of Candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7. Cell Host Microbe 20, 527\u2013534 (2016).","journal-title":"Cell Host Microbe"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31723-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:07:26Z","timestamp":1669295246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31723-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31723"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31723-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4074"}}